Jazz Pharmaceuticals PLC (JAZZ)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $15.39B
Last updated: Nov 17, 2026 at 4:20 PM ET
Jazz Pharmaceuticals PLC (JAZZ) Stock Chart
Jazz Pharmaceuticals (JAZZ) has a latest price of $240.71 on Nov 17, 2026, 9.6% below its 52-week high of $266.38. Its price rose 70.6% over the past 12 months. The month-end price rose 97.3% over the 10 years through Oct 2026, a compound annual rate of 7.0%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $252.86 in Jul 2026 and its lowest $99.74 in Mar 2020, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart JAZZ with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for JAZZ.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 4.5%, and over 6 months it rose 1.4%. The month-end price rose 70.0% over the 3 years through Oct 2026, a compound annual rate of 19.4%.
| Period | Change |
|---|---|
| 1 month | +15.5% |
| 3 months | -4.5% |
| 6 months | +1.4% |
| 12 months | +70.6% |
| 12 months, with dividends | +70.6% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +70.0% | +19.4% |
| 5 years | +62.3% | +10.2% |
| 10 years | +97.3% | +7.0% |
Price by Year
Its best calendar year was 2025, when the price rose 38.0%, and its weakest was 2021, when it fell 22.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $215.98 | +27.0% |
| 2025 | $170.00 | +38.0% |
| 2024 | $123.15 | +0.1% |
| 2023 | $123.00 | -22.8% |
| 2022 | $159.31 | +25.0% |
| 2021 | $127.40 | -22.8% |
| 2020 | $165.05 | +10.6% |
| 2019 | $149.28 | +20.4% |
| 2018 | $123.96 | -7.9% |
| 2017 | $134.65 | +23.5% |
Trading Range
The price is 5.1% above its 50-day average of $229.00 and 9.0% above its 200-day average of $220.77.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $240.71 | |
| 52-week high | $266.38 | -9.6% |
| 52-week low | $156.95 | +53.4% |
| 50-day average | $229.00 | +5.1% |
| 200-day average | $220.77 | +9.0% |
Price Risk
Over 3 years, its largest fall from a peak was 32.2%.
| Measure | Value |
|---|---|
| 1-year beta | 0.70 |
| Largest fall, 1 year | -21.6% |
| Largest fall, 3 years | -32.2% |
Valuation
Jazz Pharmaceuticals traded at 24.1x earnings at the end of 2025, against a 5-year median of 9.5x and a 10-year median of 10.0x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About JAZZ
What is JAZZ's 1-year price change?
Jazz Pharmaceuticals's price rose 70.6% over the past 12 months. With dividends included, the 12-month total return was 70.6%.
What is JAZZ's 5-year price change?
Jazz Pharmaceuticals's month-end price rose 62.3% over the 5 years through Oct 2026, a compound annual rate of 10.2%. These figures leave out dividends.
What is JAZZ's 52-week high and low?
Jazz Pharmaceuticals's 52-week high is $266.38 and its 52-week low is $156.95. Its latest price of $240.71 on Nov 17, 2026 is 9.6% below the high.
What is JAZZ's beta?
Jazz Pharmaceuticals's 1-year beta against the S&P 500 is 0.70, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 21.6%.
Is the JAZZ chart free?
Yes. Advanced Charting for JAZZ is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
JAZZ pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts